Mps-BAY1, identified by its CAS number 1309593-24-5, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. It is characterized as a small molecule inhibitor that targets specific biological pathways, often related to cancer or inflammatory diseases. The compound typically exhibits a defined molecular structure, which contributes to its biological activity and selectivity. Mps-BAY1 is known for its ability to modulate cellular processes, potentially influencing cell proliferation and apoptosis. Its pharmacological profile may include properties such as solubility, stability, and bioavailability, which are critical for its efficacy in biological systems. Additionally, studies may explore its mechanism of action, toxicity, and interaction with other biomolecules. As research progresses, the understanding of Mps-BAY1's characteristics, including its synthesis, formulation, and clinical relevance, continues to evolve, highlighting its significance in drug development and therapeutic strategies.

Mps-BAY1

1309593-24-5: Mps-BAY1, identified by its CAS number 1309593-24-5, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. It is characterized as a small molecule inhibitor that targets specific biological pathways, often related to cancer or inflammatory diseases. The compound typically exhibits a defined molecular structure, which contributes to its biological activity and selectivity. Mps-BAY1 is known for its ability to modulate cellular processes, potentially influencing cell proliferation and apoptosis. Its pharmacological profile may include properties such as solubility, stability, and bioavailability, which are critical for its efficacy in biological systems. Additionally, studies may explore its mechanism of action, toxicity, and interaction with other biomolecules. As research progresses, the understanding of Mps-BAY1's characteristics, including its synthesis, formulation, and clinical relevance, continues to evolve, highlighting its significance in drug development and therapeutic strategies.

Mps-BAY1, an MPS1 inhibitor, exhibits anticancer activity. It inhibits cell proliferation and induces cell apoptosis by activating mitotic aberrations in cancer cells, leading to overall aneuploidy and polyploidy. Mps-BAY1 is used in research pertaining to colorectal and cervical cancer.

CAS 1309593-24-5

Mps-BAY1

Mps-BAY1

Ref: TM-T200344